Suppression of cyclin D1 by plasmid-based short hairpin RNA ameliorated experimental pulmonary vascular remodeling

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• RNA Therapeutics

Background:

• Pulmonary vascular remodeling is a key feature of pulmonary hypertension.
• Cyclin D1 overexpression contributes to smooth muscle cell proliferation in pulmonary hypertension.
• Previous studies showed short hairpin RNA (shRNA) against cyclin D1 attenuated remodeling in a smoking rat model.

Purpose of the Study:

• To evaluate the efficacy of a plasmid-based shRNA targeting cyclin D1 in a monocrotaline-induced pulmonary vascular remodeling rat model.
• To investigate the impact of cyclin D1 suppression on vascular smooth muscle cell proliferation and vessel structure.

Main Methods:

• Monocrotaline injection was used to induce pulmonary vascular remodeling in rats.
• Plasmid-based shRNA targeting cyclin D1 was administered.
• Cyclin D1 expression levels were assessed in pulmonary vessels.
• Vessel muscularization and wall thickness were quantified.

Main Results:

• Monocrotaline induced significant pulmonary vascular remodeling and cyclin D1 overexpression.
• The shRNA successfully suppressed cyclin D1 upregulation in pulmonary vessels.
• Treatment with shRNA reduced the percentage of muscularized vessels and pulmonary vessel wall thickness.

Conclusions:

• Plasmid-based shRNA against cyclin D1 ameliorates monocrotaline-induced pulmonary vascular remodeling.
• Cyclin D1 is a critical mediator of pulmonary vascular remodeling.
• Targeting cyclin D1 with shRNA represents a potential therapeutic strategy for pulmonary hypertension.